Eisai will request reconsideration of initial decision for lecanemab in Australia
Go back to Eisai will request reconsideration of initial decision for lecanemab in Australia| BARNES GROUP, Inc. (NYSE: B) | Delayed: 40.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.10 | 52 Week High | $44.27 | |||
| Open | $40.10 | 52 Week Low | $30.07 | |||
| Day High | $40.10 | P/E | 30.61 | |||
| Day Low | $40.10 | EPS | $1.31 | |||
| Volume | 10,762 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 6.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $8.73 | |||
| Open | $6.81 | 52 Week Low | $2.86 | |||
| Day High | $6.81 | P/E | N/A | |||
| Day Low | $6.81 | EPS | $-3.82 | |||
| Volume | 30 | |||||
